JP2013530689A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013530689A5 JP2013530689A5 JP2013513806A JP2013513806A JP2013530689A5 JP 2013530689 A5 JP2013530689 A5 JP 2013530689A5 JP 2013513806 A JP2013513806 A JP 2013513806A JP 2013513806 A JP2013513806 A JP 2013513806A JP 2013530689 A5 JP2013530689 A5 JP 2013530689A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid molecule
- sharing
- sequence
- exonuclease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000039446 nucleic acids Human genes 0.000 claims 43
- 108020004707 nucleic acids Proteins 0.000 claims 43
- 150000007523 nucleic acids Chemical class 0.000 claims 43
- 238000000034 method Methods 0.000 claims 19
- 108060002716 Exonuclease Proteins 0.000 claims 10
- 102000013165 exonuclease Human genes 0.000 claims 10
- 150000001413 amino acids Chemical class 0.000 claims 6
- 238000000137 annealing Methods 0.000 claims 5
- 108090000623 proteins and genes Proteins 0.000 claims 5
- 102000004169 proteins and genes Human genes 0.000 claims 5
- 230000006801 homologous recombination Effects 0.000 claims 4
- 238000002744 homologous recombination Methods 0.000 claims 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 239000013599 cloning vector Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 230000037361 pathway Effects 0.000 claims 2
- 238000010367 cloning Methods 0.000 claims 1
- 239000002299 complementary DNA Substances 0.000 claims 1
- 230000004136 fatty acid synthesis Effects 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 108091008053 gene clusters Proteins 0.000 claims 1
- 229930000044 secondary metabolite Natural products 0.000 claims 1
- 239000013598 vector Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1009732.7A GB201009732D0 (en) | 2010-06-10 | 2010-06-10 | Direct cloning |
| GB1009732.7 | 2010-06-10 | ||
| PCT/IB2011/052549 WO2011154927A2 (en) | 2010-06-10 | 2011-06-10 | Direct cloning |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016093169A Division JP2016135158A (ja) | 2010-06-10 | 2016-05-06 | 直接クローニング |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013530689A JP2013530689A (ja) | 2013-08-01 |
| JP2013530689A5 true JP2013530689A5 (enExample) | 2014-07-10 |
| JP5934196B2 JP5934196B2 (ja) | 2016-06-15 |
Family
ID=42471456
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013513806A Active JP5934196B2 (ja) | 2010-06-10 | 2011-06-10 | 直接クローニング |
| JP2016093169A Pending JP2016135158A (ja) | 2010-06-10 | 2016-05-06 | 直接クローニング |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016093169A Pending JP2016135158A (ja) | 2010-06-10 | 2016-05-06 | 直接クローニング |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US10443051B2 (enExample) |
| EP (2) | EP3138921A1 (enExample) |
| JP (2) | JP5934196B2 (enExample) |
| CN (2) | CN103068995B (enExample) |
| CA (1) | CA2802167C (enExample) |
| GB (1) | GB201009732D0 (enExample) |
| SG (1) | SG186219A1 (enExample) |
| WO (1) | WO2011154927A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201009732D0 (en) | 2010-06-10 | 2010-07-21 | Gene Bridges Gmbh | Direct cloning |
| EP2612918A1 (en) * | 2012-01-06 | 2013-07-10 | BASF Plant Science Company GmbH | In planta recombination |
| CN102558309B (zh) * | 2012-02-10 | 2014-09-17 | 浙江大学 | 一对转录激活子样效应因子核酸酶及其编码基因与应用 |
| CN102627691B (zh) * | 2012-04-05 | 2014-09-17 | 浙江大学 | 一对转录激活子样效应因子核酸酶及其编码基因与应用 |
| JP6275120B2 (ja) * | 2012-04-25 | 2018-02-07 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 大きい標的化ベクターによるヌクレアーゼ媒介標的化 |
| CN102702335B (zh) * | 2012-05-23 | 2014-07-09 | 上海斯丹赛生物技术有限公司 | 重组转录激活子样效应因子、转录激活子样效应因子核酸酶及其编码基因及应用 |
| US20150267210A1 (en) | 2012-10-16 | 2015-09-24 | Genebridges Gmbh | Electrocompetent cells and preparation thereof |
| EP3456831B1 (en) | 2013-04-16 | 2021-07-14 | Regeneron Pharmaceuticals, Inc. | Targeted modification of rat genome |
| MX388127B (es) | 2013-12-11 | 2025-03-19 | Regeneron Pharma | Metodos y composiciones para la modificacion dirigida de un genoma. |
| AU2014368982B2 (en) * | 2013-12-19 | 2021-03-25 | Amyris, Inc. | Methods for genomic integration |
| BR112016028564A2 (pt) | 2014-06-06 | 2018-01-30 | Regeneron Pharma | método para modificar um locus-alvo em uma célula. |
| MX384887B (es) | 2014-06-23 | 2025-03-14 | Regeneron Pharma | Ensamblaje de adn mediado por nucleasa. |
| SG10201911411YA (en) | 2014-06-26 | 2020-02-27 | Regeneron Pharma | Methods and compositions for targeted genetic modifications and methods of use |
| CA3176380A1 (en) | 2014-11-21 | 2016-05-26 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for targeted genetic modification using paired guide rnas |
| CN105713885B (zh) * | 2014-12-04 | 2019-06-11 | 清华大学 | 特异识别并修复β地中海贫血症beta-globin基因的嵌合核酸酶 |
| BR112017013104A2 (pt) * | 2014-12-19 | 2018-05-15 | Regeneron Pharma | métodos para modificar um locus genômico alvo em uma célula, para intensificar a recombinação homóloga em um locus genômico alvo em uma célula e para produzir uma geração f0 de um animal não humano. |
| CN105734061B (zh) * | 2016-03-25 | 2019-07-23 | 中国农业科学院生物技术研究所 | 从毕赤酵母中分离的鼠李糖诱导型启动子及其应用 |
| CN109715813A (zh) * | 2016-04-06 | 2019-05-03 | 基因桥有限公司 | 腺病毒载体 |
| CN106995813B (zh) * | 2017-03-23 | 2020-06-16 | 山东大学 | 基因组大片段直接克隆和dna多分子组装新技术 |
| CN109385417A (zh) * | 2017-08-03 | 2019-02-26 | 华东理工大学 | 体内dna无缝组装方法 |
| MX2021012158A (es) * | 2019-04-05 | 2022-01-06 | Danisco Us Inc | Métodos para la integración de una secuencia de adn donante en el genoma de bacillus usando constructos de adn recombinante lineal y composiciones de los mismos. |
| CN110184287B (zh) * | 2019-05-24 | 2024-01-30 | 华南农业大学 | 一种制备重组病毒的方法及其应用 |
| CN114630910A (zh) | 2019-06-25 | 2022-06-14 | 伊纳瑞农业技术有限公司 | 改善的同源依赖修复基因组编辑 |
| CN115717152A (zh) * | 2022-11-29 | 2023-02-28 | 江南大学 | 一种控制枯草芽孢杆菌基因组同源重组概率的方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5043272A (en) | 1989-04-27 | 1991-08-27 | Life Technologies, Incorporated | Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers |
| US5776744A (en) * | 1995-06-07 | 1998-07-07 | Yale University | Methods and compositions for effecting homologous recombination |
| ATE449844T1 (de) | 1997-12-05 | 2009-12-15 | Europ Lab Molekularbiolog | Neue methode zur klonierung dns unter anwendung des e. coli rece/rect rekombinationssystems |
| AUPP684998A0 (en) * | 1998-10-30 | 1998-11-26 | Murdoch Institute for Research into Birth Defects Limited, The | A method of recombination and agents useful for same |
| US6355412B1 (en) * | 1999-07-09 | 2002-03-12 | The European Molecular Biology Laboratory | Methods and compositions for directed cloning and subcloning using homologous recombination |
| US6569681B1 (en) * | 2000-03-14 | 2003-05-27 | Transkaryotic Therapies, Inc. | Methods of improving homologous recombination |
| EP1399546A2 (en) | 2001-02-09 | 2004-03-24 | Gene Bridges GmbH | Recombination method |
| WO2003010322A1 (en) * | 2001-07-20 | 2003-02-06 | Youming Zhang | Improved rect or recet cloning and subcloning method |
| EP1590468A2 (en) * | 2003-01-28 | 2005-11-02 | Cellectis | Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| WO2007013979A2 (en) | 2005-07-20 | 2007-02-01 | Invitrogen Corporation | Methods for increasing efficiency of homologous recombination |
| KR100681815B1 (ko) * | 2005-12-02 | 2007-02-12 | 한국생명공학연구원 | 리컴비네이즈 매개 선택표지 유전자 발현유도에 의한 목표유전자 간편 클로닝 및 목표 단백질 신속 발현 방법. |
| EP2027313B1 (en) * | 2006-03-27 | 2012-05-16 | Children's Hospital & Regional Medical Center | Compositions and methods comprising the use of cell surface displayed homing endonucleases |
| GB0803109D0 (en) * | 2008-02-20 | 2008-03-26 | Gene Bridges Gmbh | Method of nucleic acid recombination |
| JP2011217736A (ja) * | 2010-03-26 | 2011-11-04 | Aichi Medical Univ | 組換えクラミジア及びその製造方法 |
| GB201009732D0 (en) * | 2010-06-10 | 2010-07-21 | Gene Bridges Gmbh | Direct cloning |
-
2010
- 2010-06-10 GB GBGB1009732.7A patent/GB201009732D0/en not_active Ceased
-
2011
- 2011-06-10 JP JP2013513806A patent/JP5934196B2/ja active Active
- 2011-06-10 EP EP16192084.8A patent/EP3138921A1/en not_active Withdrawn
- 2011-06-10 EP EP11729474.4A patent/EP2580338B1/en active Active
- 2011-06-10 CA CA2802167A patent/CA2802167C/en active Active
- 2011-06-10 CN CN201180038908.6A patent/CN103068995B/zh active Active
- 2011-06-10 CN CN201810875866.5A patent/CN109825486A/zh active Pending
- 2011-06-10 US US13/806,086 patent/US10443051B2/en active Active
- 2011-06-10 WO PCT/IB2011/052549 patent/WO2011154927A2/en not_active Ceased
- 2011-06-10 SG SG2012090056A patent/SG186219A1/en unknown
-
2016
- 2016-05-06 JP JP2016093169A patent/JP2016135158A/ja active Pending
-
2019
- 2019-09-06 US US16/563,274 patent/US12195732B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013530689A5 (enExample) | ||
| JP2011004753A5 (enExample) | ||
| CA3062698A1 (en) | Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof | |
| JP2014514921A5 (enExample) | ||
| WO2013186563A3 (en) | Factor viii sequences | |
| WO2014202616A3 (en) | Rasamsonia gene and use thereof | |
| EP4227415A3 (en) | Capsid-free aav vectors, compositions, and methods for vector production and gene delivery | |
| JP2011062217A5 (enExample) | ||
| FI3604532T3 (fi) | Uusia crispr-entsyymejä ja järjestelmiä | |
| MX392247B (es) | Composiciones detergentes. | |
| MX2020005458A (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
| UA110599C2 (uk) | Пептид для імунотерапії пухлин, включаючи нейрональні пухлини та пухлини мозку | |
| MY176331A (en) | Carbohydrate degrading polypeptide and uses thereof | |
| JP2010273685A5 (enExample) | ||
| CA2999534C (en) | Glucoamylase variants and polynucleotides encoding same | |
| EP3929285A3 (en) | Methods of reducing odor | |
| JP2015533791A5 (enExample) | ||
| HK1198170A1 (en) | Pseudomonas exotoxin a with less immunogenic b cell epitopes | |
| EA201170715A1 (ru) | Вектор, содержащий множественные гомологичные нуклеотидные последовательности | |
| WO2013189972A3 (en) | Use of polypeptides having protease activity in animal feed and detergents | |
| EA201300056A1 (ru) | Полипептид с активностью ацетилксиланэстеразы и его применения | |
| JP2011521661A5 (enExample) | ||
| IN2015DN03206A (enExample) | ||
| MX2019000139A (es) | Polipeptidos que tienen actividad xilanasa y polinucleotidos que los codifican. | |
| WO2013052814A8 (en) | E1 enzyme mutants and uses thereof |